Why is Nectar Lifesci. falling/rising?

As of 18-Nov, Nectar Lifescience Ltd is experiencing a decline in its stock price, currently at Rs 13.75, which represents a decrease of 0.89 or 6.08%. The stock has been underperforming significantly, with a consecutive fall over the last three days resulting in a total drop of 13.63%. It is currently trading lower than all key moving averages, including the 5-day, 20-day, 50-day, 100-day, and 200-day averages. Additionally, the stock is close to its 52-week low, just 3.64% away from Rs 13.25. The delivery volume has also decreased by 22.67% compared to the 5-day average, indicating falling investor participation. The stock's year-to-date performance shows a staggering decline of 64.74%, contrasting sharply with the Sensex's gain of 8.36%.
In the broader market context, Nectar Lifescience's short-term performance has been notably poor compared to the benchmark, as it has declined by 5.43% over the past week while the Sensex has increased by 0.96%. This underperformance extends to longer periods as well, with the stock down 0.72% over the past month, while the Sensex has risen by 0.86%. The stark contrast in returns over various time frames highlights the challenges faced by Nectar Lifescience in attracting investor confidence, further exacerbated by the overall market's positive trajectory.